Chief Legal Officer Sells $3.3M in Stock Amidst Recent Financial Declines
MOH sits 58% above its 52-week low of $121.06 on light trading volume (0.4× avg).
Summary
Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, sold over $3.3 million worth of common stock, marking a significant insider disposition following recent disappointing Q1 earnings.
Key Events · Ownership and Investor Activity · MOH
-
Chief Legal Officer Sells Shares
Jeff D. Barlow, Chief Legal Officer, sold 17,811 shares of common stock for a total value of $3,314,983.32 on May 11, 2026.
-
Significant Executive Disposition
This transaction represents a substantial personal disposition by a C-suite executive, reducing his direct holdings to 67,175 shares.
-
Timing Post-Earnings
The sale occurred shortly after Molina Healthcare reported a significant 95% decline in Q1 diluted EPS and a 4% drop in premium revenue.
-
Context of Recent Corporate Events
The sale took place on the same day stockholders approved an increase to the equity incentive plan, and after the company outlined ambitious 2029 targets at its Investor Day.
Analysis · MOH · Finance
This substantial insider sale by a key executive could be interpreted negatively by investors, especially coming shortly after the company reported a significant 95% drop in Q1 diluted EPS and a 4% decline in premium revenue. While the company recently presented ambitious 2029 financial targets at its Investor Day, this sale might signal a lack of personal conviction from a C-suite member.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.9% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MOH was trading at $190.95 on NYSE in the Finance sector, with a market capitalization of approximately $10B. The 52-week trading range was $121.06 to $327.68. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.